tiprankstipranks
Trending News
More News >
Alibaba Health Information Technology Ltd. (HK:0241)
:0241

Alibaba Health Information Technology (0241) Stock Statistics & Valuation Metrics

Compare
17 Followers

Total Valuation

Alibaba Health Information Technology has a market cap or net worth of $72.39B. The enterprise value is ―.
Market Cap$72.39B
Enterprise Value

Share Statistics

Alibaba Health Information Technology has 16,093,007,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,093,007,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

Alibaba Health Information Technology’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.57%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.57%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee19.01M
Profits Per Employee660.62K
Employee Count1,422
Asset Turnover1.37
Inventory Turnover15.10

Valuation Ratios

The current PE Ratio of Alibaba Health Information Technology is 45.22. Alibaba Health Information Technology’s PEG ratio is 18.80.
PE Ratio45.22
PS Ratio0.00
PB Ratio4.34
Price to Fair Value2.75
Price to FCF68.18
Price to Operating Cash Flow58.48
PEG Ratio18.80

Income Statement

In the last 12 months, Alibaba Health Information Technology had revenue of 27.03B and earned 883.48M in profits. Earnings per share was 0.06.
Revenue27.03B
Gross Profit5.90B
Operating Income872.40M
Pretax Income939.40M
Net Income883.48M
EBITDA999.05M
Earnings Per Share (EPS)0.06

Cash Flow

In the last 12 months, operating cash flow was 1.08B and capital expenditures -22.77M, giving a free cash flow of 1.06B billion.
Operating Cash Flow1.08B
Free Cash Flow1.06B
Free Cash Flow per Share0.07

Dividends & Yields

Alibaba Health Information Technology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.12
52-Week Price Change46.58%
50-Day Moving Average4.93
200-Day Moving Average4.09
Relative Strength Index (RSI)37.66
Average Volume (3m)75.48M

Important Dates

Alibaba Health Information Technology upcoming earnings date is Dec 2, 2025, TBA Not Confirmed.
Last Earnings DateMay 19, 2025
Next Earnings DateDec 2, 2025
Ex-Dividend Date

Financial Position

Alibaba Health Information Technology as a current ratio of 2.69, with Debt / Equity ratio of 0.56%
Current Ratio2.69
Quick Ratio2.41
Debt to Market Cap0.00
Net Debt to EBITDA-9.48
Interest Coverage Ratio146.16

Taxes

In the past 12 months, Alibaba Health Information Technology has paid 56.26M in taxes.
Income Tax56.26M
Effective Tax Rate0.06

Enterprise Valuation

Alibaba Health Information Technology EV to EBITDA ratio is 30.51, with an EV/FCF ratio of 28.84.
EV to Sales1.13
EV to EBITDA30.51
EV to Free Cash Flow28.84
EV to Operating Cash Flow28.23

Balance Sheet

Alibaba Health Information Technology has $9.55B in cash and marketable securities with ¥82.17M in debt, giving a net cash position of -$9.47B billion.
Cash & Marketable Securities$9.55B
Total Debt¥82.17M
Net Cash-$9.47B
Net Cash Per Share-$0.59
Tangible Book Value Per Share$0.95

Margins

Gross margin is 21.81%, with operating margin of 3.23%, and net profit margin of 3.27%.
Gross Margin21.81%
Operating Margin3.23%
Pretax Margin3.48%
Net Profit Margin3.27%
EBITDA Margin3.70%
EBIT Margin3.50%

Analyst Forecast

The average price target for Alibaba Health Information Technology is $6.18, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.18
Price Target Upside37.43% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-1.97%
EPS Growth Forecast25.45%

Scores

Smart Score9
AI Score74
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis